Grants and Contracts Details
Description
This award is only for site preparedness funds to prepare for participation in Phase III clinical trials described below. Preparedness funds can go to hiring and training of new staff, preparation of mobile research units, procurement of clinical or local lab equipment, supplies, and community outreach. This prepares for clinical trials as described here:
CoVPN 3006 Cohorts (4 total)
Main cohort
University Students
Randomized to immediate or delayed vaccination (1:1, individual randomization)
Approximately five months of followup
Prospective Close Contact cohort (PCC)
Close contacts of Main cohort participants identified at study start (or throughout)
Contacts will enroll online with a referral code that links them to the vaccine study participant
Some sample collection if self or main study participant tests positive (to be done remotely/mobile/self-collection)
Case-Ascertained Close Contact cohort (CACC)
Recent contacts of Main cohort participants close to infection (need not be students)
Contacts will enroll online with a referral code that links them to the vaccine study participant
Some sample collection (to be done rem2o0tely/mobile/self-collection)
Status | Finished |
---|---|
Effective start/end date | 2/1/21 → 11/30/21 |
Funding
- Fred Hutchinson Cancer Research Center: $90,820.00
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.